Allegra Orthopaedics Limited designs, sells, and distributes surgical implants in Australia.
Adequate balance sheet and overvalued.
Share Price & News
How has Allegra Orthopaedics's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AMT's share price has been volatile over the past 3 months.
7 Day Return
AU Medical Equipment
1 Year Return
AU Medical Equipment
Return vs Industry: AMT underperformed the Australian Medical Equipment industry which returned 44.2% over the past year.
Return vs Market: AMT underperformed the Australian Market which returned 14.8% over the past year.
Price Volatility Vs. Market
How volatile is Allegra Orthopaedics's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StIs Allegra Orthopaedics Limited's (ASX:AMT) CEO Overpaid Relative To Its Peers?
2 months ago | Simply Wall StHealth Check: How Prudently Does Allegra Orthopaedics (ASX:AMT) Use Debt?
3 months ago | Simply Wall StThe Allegra Orthopaedics (ASX:AMT) Share Price Has Gained 142%, So Why Not Pay It Some Attention?
Is Allegra Orthopaedics undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate AMT's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate AMT's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: AMT is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.
PE vs Market: AMT is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AMT's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AMT is good value based on its PB Ratio (2.5x) compared to the AU Medical Equipment industry average (4.4x).
How is Allegra Orthopaedics forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allegra Orthopaedics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Allegra Orthopaedics's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Allegra Orthopaedics competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Allegra Orthopaedics performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AMT has high quality earnings.
Growing Profit Margin: AMT's current net profit margins (-16.3%) are lower than last year (-11.5%).
Past Earnings Growth Analysis
Earnings Trend: AMT is unprofitable, but has reduced losses over the past 5 years at a rate of 6.7% per year.
Accelerating Growth: Unable to compare AMT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AMT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (29.5%).
Return on Equity
High ROE: AMT has a negative Return on Equity (-14.74%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
How is Allegra Orthopaedics's financial position?
Financial Position Analysis
Short Term Liabilities: AMT's short term assets (A$5.5M) exceeds its short term liabilities (A$1.1M)
Long Term Liabilities: AMT's short term assets (5.5M) exceeds its long term liabilities (61.1K)
Debt to Equity History and Analysis
Debt Level: AMT's debt to equity ratio (1.5%) is considered satisfactory
Reducing Debt: AMT's debt to equity ratio has reduced from 22.7% to 1.5% over the past 5 years.
Inventory Level: AMT has a high level of physical assets or inventory.
Debt Coverage by Assets: AMT's debt is covered by short term assets (assets are 65.2x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AMT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AMT has less than a year of cash runway if free cash flow continues to reduce at historical rates of -28.5% each year
What is Allegra Orthopaedics's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate AMT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate AMT's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AMT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AMT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AMT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
What is the CEO of Allegra Orthopaedics's salary, the management and board of directors tenure and is there insider trading?
Average management tenure
Jenny Swain 0
Ms. Jenny Swain has been the Chief Executive Officer of Allegra Orthopaedics Limited since May 2, 2016. Ms. Swain served as Director Sales and Marketing of Allegra Orthopaedics Limited and served as its N ...
CEO Compensation Analysis
Compensation vs Market: Jenny's total compensation ($USD227.73K) is about average for companies of similar size in the Australian market ($USD258.27K).
Compensation vs Earnings: Jenny's compensation has been consistent with company performance over the past year.
Management Age and Tenure
Experienced Management: AMT's management team is considered experienced (2.8 years average tenure).
Board Age and Tenure
Experienced Board: AMT's board of directors are considered experienced (4 years average tenure).
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.6%.
- Tenure: 2.8yrs
Chief Executive Officer
- Tenure: 3.5yrs
- Compensation: AU$332.98k
Commercial & Finance Manager
- Tenure: 2.8yrs
- Compensation: AU$128.83k
Tony Hartnell (77yo)
- Tenure: 5yrs
- Compensation: AU$46.07k
Peter Kazacos (65yo)
- Tenure: 4.1yrs
- Compensation: AU$63.59k
Sean St Mulhearn (56yo)
- Tenure: 4yrs
- Compensation: AU$46.07k
- Tenure: 1.7yrs
- Compensation: AU$45.00k
Allegra Orthopaedics Limited's company bio, employee growth, exchange listings and data sources
- Name: Allegra Orthopaedics Limited
- Ticker: AMT
- Exchange: ASX
- Founded: 1994
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: AU$13.938m
- Shares outstanding: 99.56m
- Website: https://www.allegraorthopaedics.com
- Allegra Orthopaedics Limited
- 18-20 Orion Road
- Level 8
- Lane Cove West
- New South Wales
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|AMT||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Dec 2007|
Allegra Orthopaedics Limited designs, sells, and distributes surgical implants in Australia. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and u ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2019/11/13 10:34|
|End of Day Share Price||2019/11/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.